Tuesday, January 31, 2017 5:32:13 PM
WELL... Mostly just for fun thought I'd open a thought.
Back in June it looked like this..
CEO... "The phase two clinical trial will be a pivotal phase two in the sense that we can go to commercialization after that without going to phase 3." (Theralase website 8:14 STSIntervew)
Of Course we know we have three trials here right? (RE IHUB post 2466)
Well I'm considering we could possibly have two pivotal trials coming up. It's possible we could fail our 1b trial. It's possible we could have success with two pivotal trials.
I happen to respect Rodger and think he is impressive. JMO He said there would be a thirty day follow up after at 1b trial. There is a thirty day follow up. That went back and forth a bit but at the end of the day his word held.
Perhaps ph2 trial will be BSG reoccurrence pivotal.
And then the tougher sell of the ph3 trial with solid tumor pivotal trial. JMO here!!!
And if it happens Rodger's word will hold again.
Back in June it looked like this..
CEO... "The phase two clinical trial will be a pivotal phase two in the sense that we can go to commercialization after that without going to phase 3." (Theralase website 8:14 STSIntervew)
Of Course we know we have three trials here right? (RE IHUB post 2466)
Well I'm considering we could possibly have two pivotal trials coming up. It's possible we could fail our 1b trial. It's possible we could have success with two pivotal trials.
I happen to respect Rodger and think he is impressive. JMO He said there would be a thirty day follow up after at 1b trial. There is a thirty day follow up. That went back and forth a bit but at the end of the day his word held.
Perhaps ph2 trial will be BSG reoccurrence pivotal.
And then the tougher sell of the ph3 trial with solid tumor pivotal trial. JMO here!!!
And if it happens Rodger's word will hold again.
Recent TLTFF News
- Theralase(R) Closes $CAN 2.66 Million Financing • Newsfile • 04/10/2026 11:00:00 AM
- Theralase(R) Closes $1.1 M Non-Brokered Private Placement • Newsfile • 03/10/2026 11:00:00 AM
- Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer • Newsfile • 03/09/2026 11:00:00 AM
- Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress • Newsfile • 02/20/2026 12:00:00 PM
- Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress • Newsfile • 02/17/2026 12:00:00 PM
- Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting • Newsfile • 02/10/2026 12:00:00 PM
- Theralase(R) Provides Update on Bladder Cancer Clinical Study • Newsfile • 02/04/2026 12:00:00 PM
- Theralase and Ferring ink deal for new bladder cancer study • IH Market News • 01/14/2026 11:05:00 AM
- New Bladder Cancer Collaboration Sparks Sharp Rally in This Micro Cap Stock • AllPennyStocks.com • 01/12/2026 03:23:00 PM
- Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer • Newsfile • 01/12/2026 12:00:00 PM
- Theralase(R) Closes $1.3 M Non-Brokered Private Placement • Newsfile • 12/23/2025 09:40:00 PM
- Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing • Newsfile • 12/12/2025 10:00:00 PM
- Theralase(R) Investor Conference Call Reminder • Newsfile • 11/17/2025 12:00:00 PM
- Theralase(R) Releases 3Q2025 Financial Statements • Newsfile • 11/10/2025 12:00:00 PM
- Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus • Newsfile • 09/24/2025 11:00:00 AM
